United States · FDA National Drug Code directory
TRIESENCE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82667-800_5386eec5-c123-04b8-e063-6294a90a2952
- Product NDC
- 82667-800
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- triamcinolone acetonide
- Labeler
- Harrow Eye, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20241001
- Source listing expiry
- 20271231
Source-listed ingredients
- TRIAMCINOLONE ACETONIDE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (82667-800-01) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS · 82667-800-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →